Why AVIR? Atea Pharmaceuticals, Inc. Analysis, Price & AI Insights | Whystock
AVIR
$5.70+0.12 (+2.15%)
After Hours$5.70+0.00 (+0.00%)· Last close May 4
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.